Finance

Lists
Why is SVA down 4,35%?
Dive Deeper
SVA:TSE
Sernova Biotherapeutics Inc
0,11 CA$
-4,35%
(-0,0050) 1D
13 հոկ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
0,11 CA$
High
0,12 CA$
Low
0,11 CA$
Mkt. cap
39,81 մլն
Avg. vol.
351,90 հզր
Volume
33,83 հզր
52-wk high
0,20 CA$
52-wk low
0,08 CA$
EPS
-0,03 CA$
Beta
32,05
Shares outstanding
377,64 մլն
No. of employees
8
Open
0,11 CA$
High
0,12 CA$
Low
0,11 CA$
Mkt. cap
39,81 մլն
Avg. vol.
351,90 հզր
Volume
33,83 հզր
52-wk high
0,20 CA$
52-wk low
0,08 CA$
EPS
-0,03 CA$
Beta
32,05
Shares outstanding
377,64 մլն
No. of employees
8
News stories
From web sources and news partners
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersԼոնդոն, Օնտարիո, Կանադա
Sector-
Last report
10 սեպ, 2026 թ.
Fiscal period
Q3 2026
-0,01 CA$ / -0,00 CA$
-100,00%miss
Revenue / Est. (CAD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. հոկ
2026 թ. հնվ
2026 թ. ապր
2026 թ. հլս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
809,63 հզր
434,15 հզր
444,87 հզր
432,62 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,59 մլն
1,68 մլն
1,85 մլն
1,69 մլն
Operating expense
2,40 մլն
2,12 մլն
2,30 մլն
2,12 մլն
Total operating expenses
2,40 մլն
2,12 մլն
2,30 մլն
2,12 մլն
Operating income
-2,40 մլն
-2,12 մլն
-2,30 մլն
-2,12 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-2,25 մլն
-2,41 մլն
-3,23 մլն
-2,57 մլն
EBT excluding unusual items
-2,26 մլն
-2,41 մլն
-3,23 մլն
-2,57 մլն
Income tax expense
-54,97 հզր
-72,00 հզր
-
-45,00 հզր
Effective tax rate
2,44%
2,99%
-
1,75%
Other operating expenses
-
-
-
-
Net income
-2,20 մլն
-2,33 մլն
-3,23 մլն
-2,53 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,01
-0,01
-0,01
-0,01
Interest and investment income
260,60 հզր
-
413,00
-
Interest expense
-
-477,12 հզր
-920,95 հզր
-260,18 հզր
Net interest expenses
260,60 հզր
-477,12 հզր
-920,53 հզր
-260,18 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,34 մլն
-2,11 մլն
-2,29 մլն
-2,11 մլն
Gain or loss from assets sale
-4,25 հզր
-
-
-
AI content may include mistakes. Learn more
Google Apps